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Introduction
Syndromes characterized by clusters of
somatic symptoms that remain medically
unexplained are common in all areas of medi-
cine. Many of these—such as irritable bowel
syndrome, dyspnea, sick building syndrome,
and mitral valve prolapse—are frequently seen
in both primary and specialty care settings.
Regardless of the label used to describe any of
these syndromes, taken as a whole they repre-
sent one of the most frustrating and
intractable puzzles in primary and specialty
care. In fact, research in primary care settings
throughout the world has shown that in about
one-third of primary care patients, no organic
(i.e., nonfunctional) diagnosis can be offered
as a reasonably firm medical explanation for
the physical complaints. Put another way, in
the majority of cases (or about two-thirds of
patients) no allopathic disease entity can be
differentially diagnosed and unequivocally
established as the principal determinant of a
given patient’s presenting somatic complaints
(Ustun and Sartorius 1995). The situation is
similar in specialty care. In fact, a study of the
most frequent visitors to specialty clinics
shows that no ﬁrm diagnosis can be proffered
for over 20% of the patient care episodes gen-
erated by the most frequent visitors to spe-
cialty care clinics (Reid et al. 2001). Finally,
research has shown that a full or subthreshold
mental disorder can be reliably diagnosed and
alternatively account for the presenting physi-
cal complaints of at least one-third of primary
care patients who present with physical
symptoms (Ustun and Sartorius 1995). 
In this article we will discuss the common
features uniting the functional somatic syn-
dromes as a class. By emphasizing the com-
mon characteristics or overarching elements
of these disorders, we do not mean to imply
that specific disorders (e.g., fibromyalgia)
within this somatic syndromes classification
do not have distinctive features that are
important for research and clinical manage-
ment, or does this discussion of functional
somatic syndromes as a class imply that this
class should be construed as a sturdy disease
entity akin to diabetes in internal medicine or
Alzheimer’s disease in psychiatry. In consider-
ing functional syndromes qua class, we brieﬂy
discuss nosological issues, clinical assessment
of unexplained symptoms, notions about
these syndromes that are adumbrated within
the various specialties, clinical management,
and treatment. A conceptual framework
steeped in both psychiatry and psychology
will frame the discussion throughout. This
approach is taken despite the fact that
affected patients and advocates of the speciﬁc
functional somatic syndromes tend to be
wary of, if not hostile to, the psychiatric per-
spective as applied to these conditions. In the
interest of full disclosure, note that the first
author is a practicing and teaching research
psychiatrist, and the co-authors are clinical
and research psychologists.
Nosological Issues
Numerous descriptive labels have been applied
to cases of multiple unexplained physical
symptoms. These labels range from often-
pejorative colloquial and pseudotechnical terms
to the sometimes trendier specialty-speciﬁc syn-
drome labels. A number of terms that describe
a majority of these clusters of medically unex-
plained symptoms have been accumulating in
the literature for several decades. These terms
include somatization, somatization symptoms,
medically unexplained physical symptoms,
multiple medically unexplained symptoms,
persistent symptom syndromes, symptom-
based conditions (Hyams 1998), functional
somatic symptoms, and functional somatic
syndromes, among others.
Several of the medical specialties have
proposed a number of specialty-speciﬁc labels
to designate these rather vague, nonspecific
syndromes. Although incorporating remark-
ably similar clinical features, these specialty-
specific labels inevitably assume a parochial
paradigm, implying that the syndrome under
scrutiny may be unique to that given specialty,
thus selectively emphasizing certain body
organs or symptom clusters instead of others.
In doing this, the specialties assimilate the
phenomena into preconceived nomenclatures,
modeling them after currently favored theories
of etiology, course, and treatment. Often, the
ﬁt of phenomena to specialty models is some-
what forced and lacks scientiﬁc rigor. For this
reason, and because there is no “gold stan-
dard” against which these syndromes can be
evaluated, the use of more generic descriptors
rather than diagnostic labels should be the
preferred strategy for the systematic investiga-
tion of these entities. Some of the specific
labels coined by specialists have been
endorsed, incorporated, vigorously elaborated,
and made popular by afflicted patients, the
media, and advocacy groups, even though
these labels do not refer to well-established,
bona fide medical disorders. Inevitably, cer-
tain labels used for these syndromes “stick”
more and attain a more “glamorous” or less-
stigmatizing status than others. In the end, the
social desirability of the labels inﬂuences their
clinical use by physicians, acceptance by
patients, and degree of mass consumption by
news media and advocacy groups. 
Functional Somatic Syndromes
In the past few years, medical journals such as
The Lancet, British Medical Journal, New
England Journal of Medicine, JAMA, Annals of
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Unexplained Symptoms
Clusters of medically unexplained physical symptoms have been referred to in the literature by
many different labels, including somatization, symptom-based conditions, and functional
somatic syndromes, among many others. The traditional medical perspective has been to classify
and study these symptoms and functional syndromes separately. In psychiatry, current tax-
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International Statistical Classification of Diseases and Related Health Problems, 10th revision)
classify these syndromes together under the rubric of somatoform disorders. In this article we
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dromes as a class. Included in this article is a discussion of nosological issues, clinical assessment,
how these syndromes are viewed within the various medical specialties, and clinical management
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Internal Medicine, and others published
research articles and reviews on the topic of
functional somatic syndromes. Although the
term functional may not be entirely accurate
in this instance, it has served as practical
umbrella to a large number of disorders across
various medical specialties characterized by a
high level of medically unexplained physical
symptoms. The latter term would serve as the
“monetary unit” of the system. Both terms
seem relatively neutral, properly descriptive,
and nonpejorative, and may be generally
acceptable to the various specialties, hence
their use throughout the article. 
Excellent reviews of these syndromes
appeared almost simultaneously on both sides
of the Atlantic (Barsky and Borus 1999;
Wessely et al. 1999), highlighting their com-
mon epidemiologic, clinical, and psycho-
pathological aspects. In our opinion, these
reviews have set the stage for the much-
needed collaborative research in this area.
Entities lumped under this “functional” cate-
gory include a long list of somatic symptom
complexes, many of which wear rather
unique “specialty outﬁts.” 
Despite the multiplicity of labels included
in Table 1, a detailed inspection of them
brings to mind the “old wine in new bottles”
adage. That is, despite their many similar
attributes, there has been a tendency over the
years to split what we view as a traditional cat-
egory within psychiatry (somatization) into
many different specialty-specific syndromes.
Yet we would emphasize that despite a smat-
tering of distinctive features, each of these
syndromes shares common elements such as
• The absence of a gold standard against
which a speciﬁc diagnosis can be conﬁrmed
or ruled out.
• The presence of multiple unexplained phys-
ical symptoms originating from several dif-
ferent organ systems.
•P sychiatric comorbidity, often in the form of
several coexisting diagnoses from the
Diagnostic and Statistical Manual of Mental
Disorders-IV (DSM-IV) (American Psychiatric
Association 1994) (e.g., depression plus panic
disorder), including personality disorders.
• No clearly articulated pathophysiology.
Despite a number of potential pathophysio-
logic mechanisms (symptom ampliﬁcation,
muscle contraction, catecholamine release,
persistent neurobiologic dysfunction, neu-
rologic hyperreactivity, elevated cortisol)
(Rief et al. 1998) enumerated as relevant to
the origin of many of these syndromes, no
clear pathophysiologic explanation has
emerged for any of them.
• No consistent explanation emanating from
physical and laboratory assessments.
• No good ﬁt with rules of allopathic medicine.
• Comparable responses to certain psycho-
logic (e.g., cognitive behavior therapy
[CBT]) and pharmacologic (e.g., anti-
depressants) interventions.
• The emergence of emotionally charged,
highly politicized patient advocacy groups.
The last point mentioned merits elabora-
tion. That is, the review articles mentioned
above stimulated an unusually large number
of responses in the form of letters to the editor
to Annals of Internal Medicine and The Lancet
(Barsky and Borus 1999; Wessely et al. 1999).
This barrage of letters consisted mainly of hos-
tile replies that appeared to be related primar-
ily to the inclusion of chronic fatigue among
these functional syndromes (Clemenger 2000;
Colby 1999; English 2000; Goudsmit 2000;
Hedrick 2000; Kurt 2000; Leonard et al.
1999; Madill 1999). It thus appears that
advocates of patients suffering from chronic
fatigue as well as those who identify with
other “medicalized” labels (e.g., Lyme disease,
environmental disorders) form highly passion-
ate and vocal groups whose virulence often
makes the headlines (Anonymous 1998). 
The Psychiatric Perspective:
Somatoform Disorders
In psychiatry these syndromes are being
classiﬁed as somatoform disorders in current
taxonomies [DSM-IV (American Psychiatric
Association 1994); International Statistical
Classification of Diseases and Related Health
Problems, 10th revision (ICD-10) (WHO
1992)] simply on the basis that the deﬁning
symptoms remain essentially unexplained
from a conventional medical perspective. The
term somatoform is a rather odd word that
borrows both a Greek (“soma”) and Latin
(“form”) root. The derived term somatization,
which refers to the manifestation of psycho-
logical distress as unexplained physical symp-
toms, is often vehemently rejected by patients
who adhere to more medicalized labels (e.g.,
chronic fatigue) to identify and substantiate
their ailments. To many of these patients and
advocates, the application of a psychiatric
label such as somatization—or even a more
common label such as major depression—
implies a lack of legitimacy or character foible.
Even in the era of modern medicine, the psy-
chiatric label continues to be stigmatized,
whereas the bona ﬁde medical diagnosis seems
to be a more convenient, fashionable, and
acceptable label for both patients and physi-
cians. Even pharmaceutical companies seem
to be aware of this phenomenon and have
responded by relabeling medications predomi-
nantly used in psychiatry, such as Wellbutrin
(Glaxo Smith Kline, Research Triangle Park,
NC) and Prozac (Eli Lilly and Co.,
Indianapolis, IN), to market them for the
treatment of other nonpsychiatric conditions
such as nicotine addiction (Wellbutrin
changed to Zyban) and premenstrual
syndromes (Prozac changed to Serafem).
Although the European criteria for soma-
tization (Goldberg and Bridges 1988)
requires patients with unexplained symptoms
also to meet criteria for a psychiatric disorder,
the North American criteria do not clearly
indicate this requirement. In our opinion, the
lack of a medical explanation by itself does
not necessarily qualify a symptom as psychi-
atric. Elsewhere, Escobar (Escobar 1995) has
provided guidelines for probes and algorithms
to determine whether the assessment and
treatment of an unexplained physical symp-
tom is likely to benefit from a psychiatric
point of view. These guidelines suggest that a
medically unexplained physical symptom is
likely to ﬁt within a psychiatric framework if
that symptom meets one or more of the fol-
lowing criteria (the more criteria present, the
more likely it is that a psychiatric consult
would be beneﬁcial):
• Symptoms are numerous and represent
several different organ systems.
•Symptoms coexist with symptoms of a
major psychiatric disorder such as major
depression or panic disorder.
• Symptoms closely follow traumatic events.
• Symptoms lead to psychological gratiﬁcation
(secondary gain).
• Symptoms represent a predictable personality
trait for the subject.
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Table 1. Functional somatic syndromes in various medical specialties.
Specialty area Functional syndromes
Allergy Food allergies
Cardiology Atypical chest pain, noncardiac pain, mitral valve prolapse
Dentistry Temporomandibular joint syndrome, atypical facial pain
Ear, nose, and throat Tinnitus, dizziness, globus syndrome
Gastroenterology Irritable bowel, nonulcer dyspepsia
Internal medicine CFS, chronic Lyme disease, hypoglycemia, chronic candidiasis
Military medicine Gulf (Persian) War syndrome
Neurology Tension headache, pseudoseizures
Obstetrics and gynecology Premenstrual syndrome, chronic pelvic pain
Occupational medicine Multiple chemical sensitivity, sick building syndrome
Orthopedics Carpal tunnel syndrome, low back pain, herniated disc
Plastic surgery Silicone-associated connective tissue disease
Pulmonary medicine Dyspnea, habit cough, laryngeal dysfunction, hyperventilation
Rehabilitation medicine Repetitious stress injury, chronic whiplash
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• Symptoms become persistent, join a
conglomerate of other symptoms, and
convey such attitudes as overuse of medical
services and dissatisfaction with medical care.
Alternatively, a medical etiology should
be vigorously pursued in the case of single
symptoms that appear de novo, point to one
to two organ systems, and are not accompa-
nied by significant symptoms of depression
or anxiety.
Somatization Disorder
Naturalistic studies in North America vali-
dated an extreme form of the syndrome origi-
nally designated as hysteria, then renamed
Briquet syndrome, and finally, somatization
disorder (SD), the term used in current
nomenclatures (Feighner et al. 1972;
Goodwin and Guze 1996; Purtell et al.
1951). SD is a chronic, disabling syndrome
presenting a facade of physical symptoms
associated with significant psychopathology
and functional disability. Individuals with SD
tend to seek care in general medicine or spe-
cialty medical settings in lieu of seeking men-
tal health services (Escobar et al. 1987; Swartz
et al. 1991). According to several studies, SD
is a rare diagnosis in the general population
(Swartz et. al. 1991) but seems to be relatively
more frequent in primary care settings
(Escobar et al. 1989; Gureje et al. 1997;
Katon et al. 1991). The evolution of the SD
diagnosis in North America shows that the
somatic symptom thresholds required for
making the diagnosis were arbitrarily set in
succeeding nomenclatures by either inﬂating
or deflating the criteria as per committee
deliberations rarely based on research data.
For example, the original criteria set forth by
the Washington University group (Feighner
et al. 1972) required the presence of 25
symptoms from a list of 59 possible symp-
toms (including depressive and psychotic
items) in addition to certain attitudinal fea-
tures (dramatic, vague, or complicated med-
ical history). DSM-III (American Psychiatric
Association 1980) transformed the SD diag-
nosis into what it is today, a simple count of
somatic symptoms, setting the threshold at
14 symptoms out of 37 possible symptoms
for males and 16 of 37 possible symptoms for
females. DSM-III-R (American Psychiatric
Association 1987) further decreased the
symptom count to 13, but the same threshold
was set for both sexes. In DSM-IV (American
Psychiatric Association 1994) the downward
trend continued, decreasing the overall num-
ber of symptoms to eight. However, the
DSM-IV criteria now required that symptoms
come from four designated organ systems.
Given what seem superficially to be slight
changes in criteria, there have been profound
effects on the kind of patient that is desig-
nated as a case (Escobar et al. 1998a).
Validating Somatization as
Categorical Diagnosis
Several decades ago, psychiatrists at
Washington University in St. Louis,
Missouri, proposed a ﬁve-step procedure for
validating psychiatric diagnoses, following a
medical model approach. These steps
included clinical description, laboratory stud-
ies, delimitation from other disorders, and fol-
low-up and family studies (Feighner et al.
1972). Unfortunately, one of those critical
steps, the objective laboratory finding (the
gold standard for many medical diagnoses)
was not applicable then and still remains elu-
sive for the majority of mental disorders.
Therefore, most mental disorders continue to
be designated with the word functional, in
efforts to distinguish them from the truly
organic or biological disorders. Unfortunately,
to further complicate matters, changes in the
nosologies continue to be rather arbitrary and
do not adhere to the tradition outlined above.
For example, the DSM-IV criteria for SD
originated from secondary analyses with mul-
tivariate methods of an old data set from
Scandinavia (Cloninger 2001). 
Given these issues and the confusing state
of affairs across specialties for classifying
these syndromes, we believe that the use of
dimensional constructs such as abridged
somatization, when used as screen or point of
entry, may facilitate the collaborative study
of these phenomena across medical special-
ties. With increased levels of cross-specialty
research, reﬁnements of these indices are sure
to follow apace.
From the Categorical to the
Dimensional: Abridged Somatization 
Our clinical and research observations
(Escobar et al. 1987) led us to view the func-
tional somatic syndromes as existing on a con-
tinuum ranging from few medically
unexplained symptoms to many, with SD
itself placed at the extreme of this frequency/
severity spectrum. In our current thinking,
any given cluster of medically unexplained
physical symptoms may have distinctive quali-
tative elements; hence the underlying taxo-
nomic model may very well be a hybrid
model, including dimensional features as well
as discontinuities. 
In the late 1980s we proposed an abridged
construct of somatization for identifying cases,
by demonstrating that lowering the threshold
for somatization to four and six symptoms for
males and females, respectively, increased the
prevalence rate of somatization cases 100-fold
relative to the full diagnosis of SD, while still
predicting all relevant outcomes (use of ser-
vices, disability, psychopathology) (Escobar
et al. 1987). Originally, the abridged somati-
zation construct was operationalized in terms
of the 37 somatic symptoms included in the
Diagnostic Interview Schedule (DIS) (Robins
et al. 1981). Since its inception, this abridged
construct of somatization, also known as
Somatic Symptom Index and Somatization
Syndrome, has been a convenient tool for
doing systematic research on somatization in
clinical and community populations. The
abridged measure has good properties, includ-
ing test-retest reliability and construct validity.
For example, the test–retest is about 0.55,
whereas the test–retest of the SD itself is negli-
gible. (Brody et al. 1998). Some of the evi-
dence on validity is cited below. There are, in
fact, more than 10 published peer-reviewed
articles relating to the external validity of the
abridged somatization construct (Andreski
et al. 1998; Canino et al. 1987; Escobar et al.
1992, 1998b; Garcia-Campayo et al. 1998;
Golding 1994; Gureje et al. 1997; Hiller et al.
1995; Johnson et al. 1996; Kapoor et al.
1995; Katon et al. 1991; Kroenke et al. 1998;
Labott et al. 1996; Smith et al. 1995; Sullivan
et al. 1993; Walker et al. 1995). The preva-
lence of high levels of unexplained physical
symptoms measured by the abridged con-
struct is in the range of 20% in primary clinics
worldwide, and it is persistent in about 50%
of those subjects (Gureje and Simon 1999).
Instruments to Study
Somatization across
Specialties
The somatic symptoms that need to be
elicited to assess somatization as defined in
the DSM criteria include neurological,
gastrointestinal, cardiopulmonary, musculo-
skeletal, female reproductive, and genito-
urinary symptoms. All of these symptoms are
included in several well-known current epi-
demiologic and clinical instruments such as
the DIS (Robins et al. 1981), the Composite
International Diagnostic Interview (CIDI)
(Wittchen et al. 1991), and the Primary Care
Evaluation of Mental Disorders (PRIME-
MD) (Spitzer et al. 1994). The systematic
use of these instruments should facilitate col-
laborative research between mental health,
primary care and specialty services.
Composite International Diagnostic
Interview Somatization Schedule
The CIDI (Wittchen et al. 1991) includes
over 40 individual items that elicit and probe
symptoms and diagnoses of SD and
hypochondriasis and also allows for the use of
other symptom thresholds such as abridged
somatization. Despite its relative length and
probing requirements, this somatic inventory
can be effectively administered to patients by
trained lay interviewers, and yields reliable
symptom counts and diagnoses. The CIDI
has been translated into many different lan-
guages, and has been used in 17 countries
successfully (Rubio-Stipec et al. 1993). 
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(Spitzer et al. 1994), is a simple, practical,
and unobtrusive questionnaire that can be
self-administered. It has been widely used in
primary care settings, where it is considered
a reliable tool in screening for mental health
problems. The PRIME-MD includes 15 key
somatic items, as well as items to assess the
presence of other mental disorders such as
major depression, panic, generalized anxi-
ety, and alcohol disorders. In our experi-
ence, this instrument has been very useful
for identifying clusters of unexplained phys-
ical symptoms while also allowing the busy
primary care physician to concurrently
screen for the other psychiatric disorders. A
threshold of three unexplained symptoms
(as assessed by the physician) has been asso-
ciated with somatization (Kroenke et al.
1997). In the case of depression, the
PRIME-MD contains two key questions,
that are highly sensitive when endorsed,
identifying virtually all patients with major
depression (96%) (Brody et al. 1998). In
addition, the one-page screener includes a
useful question to obtain the patient’s self-
assessment of his or her general health sta-
tus. When this self-assessment of physical
health differs substantially from the physi-
cian’s objective assessment (such as the
patient who describes his or her health as
poor when the physician assesses his or her
health as very good), it can be taken as a
clue that somatization may be involved in
the case. Identifying these clues can serve as
a practical point of entry for an open
discussion of the patient’s health status.
Medically Unexplained
Physical Symptoms and
Psychologic Distress
In most cultures, unexplained physical symp-
toms are viewed as nonspeciﬁc idioms of dis-
tress (Escobar 1995). For example, high levels
of medically unexplained symptoms are often
observed after exposure to a variety of trau-
matic events. In a community sample,
Golding (1994) demonstrated that individuals
at or above the abridged somatization thresh-
old were much more likely than those below
the threshold to report having experienced
sexual/physical attacks during their lifetime.
In the only prospective study to date, a study
of individuals exposed to severe ﬂash ﬂoods in
Puerto Rico, the senior author observed that a
higher number of neurological and gastroin-
testinal symptoms were reported by individu-
als directly affected by the event compared
with those in other regions of the island
(Escobar et al. 1992). Other authors have also
made similar observations of an increase in
reporting physical symptoms in front of major
disasters. In the case of children exposed to
the Chernobyl disaster, Bromet et al. (2000)
observed that high levels of somatic symptoms
continued to be reported more than a
decade after the disaster. In a prospective
study of 1,200 individuals with various
degrees of traumatic exposure, those meeting
criteria for posttraumatic stress disorder had
a 3-fold increase in levels of abridged soma-
tization compared with those without the
disorder (Andreski et al. 1998). Obviously,
no cause–effect relationship can be unam-
biguously ascribed in these instances, as it is
also likely that individuals with high levels
of somatic symptoms may be also more
likely to report negative life events. There is
usually no corroborating evidence in this
kind of research that verifies the reports of
individual respondents about life stress.
Medically Unexplained
Symptoms in Primary Care
A number of studies in primary care have used
the abridged somatization construct as the
basis for designating a case of somatization
(Escobar et al. 1998b; Gureje et al. 1997;
Katon et al. 1991; Smith et al. 1995; Sullivan
et al. 1993). This strategy has been recom-
mended as a way to promote collaborations,
reﬁne deﬁnitions, and enhance generalization
of research findings in primary care settings
(Katon et al. 1991). In primary care patients,
Kirmayer and Robbins (1991) described three
rather distinct syndromes, including symptom
amplification (hypochondriasis), somatic
equivalents of anxiety and depression, and
high levels of unexplained physical symptoms
deﬁned according to the abridged somatization
threshold. Similarly, Katon and Walker (1998)
studied a sample of primary care users at a
health maintenance organization in Seattle,
Washington, who had been classified as dis-
tressed high users of primary care services. A
large proportion of these patients met the crite-
ria for abridged somatization. Smith et al.
(1995) assessed the effects of a brief interven-
tion on relevant health outcomes in somatizing
patients from various primary care practices in
Arkansas using the abridged somatization
construct as the criterion to deﬁne a case. 
Medically Unexplained
Symptoms in Specialty Clinics
Chronic Fatigue Syndrome
In the case of chronic fatigue syndrome
(CFS), Johnson et al. (1996) used the
abridged construct on a sample of primary
care patients with CFS. The designation of a
case on the basis of these criteria effectively
separated CFS patients from healthy controls
and also from patients with depression. 
Ear, Nose, and Throat Clinics
Sullivan et al. (1993) studied patients
referred to a private otolaryngology practice
for evaluation of a persistent complaint of
dizziness. In this patient population, meeting
criteria for abridged somatization predicted
psychiatric rather than medical co-morbidity. 
Pulmonary Clinics
Labott et al. (1996) examined a small sample
of patients presenting at a specialty pul-
monary clinic with unexplained respiratory
symptoms and compared them with a group
of controls. They found that two of three
patients with unexplained symptoms, but
only one of five controls, met the abridged
somatization criteria. 
Obstetrics and Gynecology
In patients with chronic, unexplained pelvic
pain, Walker et al. (1995) found a prevalence
of abridged somatization more than 5 times
higher than that of a control group.
Psychosomatic Clinics
Hiller et al. (1995), in Germany, used the
abridged somatization construct to study a
sample of 100 patients with psychosomatic
disorders. The construct showed good dis-
criminating power in separating mild and
severe forms of somatization. 
Although these reports suggest that the
use of a somatic symptom threshold has prac-
tical value for research studies, it must be
emphasized that the abridged construct has
not been validated as a diagnosis, and that we
do not propose it as a replacement for clinical
diagnoses. It is simply a dimensional con-
struct with demonstrated usefulness for deﬁn-
ing cases that can be used for further
epidemiologic and clinical inquiry. 
Psychiatric Interventions and
Medically Unexplained
Physical Symptoms 
Two large reviews recently examined the
response of patients with several functional
somatic syndromes to antidepressant medica-
tions and CBT. In the case of antidepressants,
O’Malley et al. (1999) found an excellent
effect of these drugs on fibromyalgia,
headache, functional gastrointestinal disor-
ders, and idiopathic pain syndromes (odds
ratios ranging from 2.0 to 5.1). 
A recent review of 31 controlled psy-
chotherapy trials for the treatment of somatiz-
ing syndromes (Kroenke and Swindle 2000)
indicates that CBT looks very promising as a
treatment for many of these syndromes. The
majority of the trials reviewed (25 studies)
focused on the treatment of chronic fatigue,
irritable bowel, and pain. Results of the studies
show that although psychological distress
improved somewhat (in 38% of the studies),
physical symptoms proved to be the most
responsive to treatment (in 71% of the stud-
ies). This review demonstrates that CBT can
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independent of reducing psychological distress.
Research Support for 
the Study of Medically
Unexplained Physical
Symptoms
Unfortunately, little systematic research is cur-
rently taking place on the broad notion of
functional somatic syndromes. The situation is
even worse on the psychiatry side, as evidenced
by ongoing federally funded research on
somatoform disorders. For example, an inspec-
tion of the 2001 research portfolio of the large
National Institute of Mental Health (NIMH)
Division of Services and Interventions
Research, shows that only 1% (7 of 601)
funded grants are in the general area of
somatoform disorders. Moreover, of these
seven grants, almost one-half (3 of 7) are on
body dysmorphic disorder, an intriguing but
rare clinical entity. Even the bipolar disorder
portfolio, which has been a source of concern
for NIMH because it is considered to be quite
depleted, includes at least 3 times as many
funded grants as the area of somatoform disor-
ders. Obviously, this lack of funding may be
related to a lack of lobbying for the mental
health façade of functional syndromes on the
part of patients and their advocates. Because
the research investment in this area is so small,
it is not surprising to see that the number of
scientiﬁc publications on these broad phenom-
ena remains very low despite the high preva-
lence, morbidity, and cost of the problem. For
example, a review of publications included in
MEDLINE (2001) from 1996 to 2001 under
the topics of somatization, somatoform disor-
ders, psychophysiologic disorders, and
hypochondriasis shows that instead of increas-
ing, publications in this area have decreased in
the last few years.
Discussion
This review has outlined common features for
the functional somatic syndromes seen in var-
ious specialty areas. Although we have pre-
sented the perspective of psychiatry and
psychology, we have tried to articulate the
need for systematic research and the potential
for successful collaboration across specialties.
Our review of the literature has convinced us
that notwithstanding the diversity of labels,
the many common elements shared by these
functional syndromes suggest that we may be
dealing with closely related phenomena.
Unfortunately, although the problem of som-
atization seems to be quite prevalent and
costly in primary and specialty care, it has
been significantly understudied relative to
other areas of medicine and psychiatry. In our
view, the continuous specialization of medi-
cine, current paradigms including biological
reductionism, and stigmatization of mental
disorder are all factors that contribute to this
state of affairs. All these biases tend to be
reflected in popular as well as scientific
discourse, hence the prevailing stigma and
meager societal investment in this area.
Moreover, the continuous operation of these
factors may have contributed to the unfortu-
nate persistence of the mind–body dichotomy
beyond the 20th century. Our review, how-
ever, also outlines some promising develop-
ments. For example, in the last few years,
general medicine journals have been printing
leading articles on the subject, and collabora-
tions between specialties have begun to
sprout in both sides of the Atlantic.
Questions for Future Research
Clearly, there is a need for collaborative
research that leads to a more rational classiﬁ-
cation of these syndromes. Moreover, once
the syndromes are better classified, the
intended therapies (CBT, pharmacotherapy)
should be adjusted to the type of presenting
symptoms or syndromes and evaluated using
common, veriﬁable methodologies.
Our speciﬁc recommendations for further
collaboration and study are as follows:
• Creation of multispecialty think tanks to
study these complex syndromes. This
should include the formation of collabora-
tive research centers. For example, at our
university, we are developing an Institute
for Study of Unexplained Symptoms that
includes basic scientists as well as represen-
tatives from psychiatry, family medicine,
general internal medicine, rheumatology,
infectious disease, and neurology.
•W e advocate the use of common defini-
tions, common descriptors, and the incor-
poration of common, well-established
instruments (e.g., PRIME-MD, CIDI).
•A  useful strategy to accomplish a practical
goal would be to assess promising therapeu-
tic interventions such as CBT for these syn-
dromes across specialties.
• Lobbying efforts will be needed to increase
research allocations by government, indus-
try, and foundations for studying these
syndromes. 
•F inally, effective interventions should be
properly marketed. This is particularly
crucial in the case of psychosocial therapies.
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